| NCT07198139 | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus | NOT_YET_RECRUITING | PHASE1, PHASE2 | 2025-11-01 | 2026-10-01 | 2026-06-01 |
| NCT06160531 | Influenza Viral Challenge Study of CC-42344 in Healthy Participants | COMPLETED | PHASE2 | 2023-11-25 | 2024-07-18 | 2024-05-03 |
| NCT05977140 | CDI-988 Safety Study in Healthy Participants | COMPLETED | PHASE1 | 2023-09-27 | 2025-07-23 | 2025-05-23 |
| NCT05202379 | CC-42344 Safety Study in Healthy Participants | COMPLETED | PHASE1 | 2022-02-11 | 2023-03-29 | 2023-03-29 |
| NCT03501550 | Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL) | COMPLETED | PHASE2 | 2018-06-26 | 2019-06-07 | 2019-01-08 |
| NCT02760758 | A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects | COMPLETED | PHASE1 | 2016-04 | 2017-04 | 2017-03 |